Find and Pitch Jounalists, Get Your Story Covered

Tags: psilocybin Brain networks Neuroscience Oregon mental health care

	Profile	Recent Articles on Subject
1	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	4 Things Employers Should Know About Psychedelic Medicines - 7 days ago What’s Next for Psychedelic Medicines? - 15 days ago
2	Kristen Monaco MedPage Today	Psych Congress Roundup: Digital Tx for MDD; Esketamine Rooms; PA Contributions - 8 days ago More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease? - 2 months ago FDA Rejects MDMA-Assisted Therapy for PTSD - 3 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - 9 months ago Psychedelics for Psych Conditions Made Their Mark in 2023 - 11 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - 11 months ago Psilocybin Shows Promise in Treatment-Resistant Bipolar Type II Depression - 11 months ago
3	Mack DeGeurin Popular Science Tech policy reporter. Hosts 'The Future is Ow' podcast. New York, New York Tech PolicyReporting	This robot is being controlled by a King oyster mushroom - 2 months ago
4	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 3 months ago STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy - 3 months ago A tough week for MDMA-assisted psychotherapy - 3 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 3 months ago Psychedelic investment continues to ramp up - 9 months ago
5	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The Uncertain Path Forward for Psychedelic Medicine - 3 months ago The FDA Just Rejected a Bid for MDMA to Treat PTSD - 3 months ago They Had PTSD. A Psychedelic Called Ibogaine Helped Them Get Better - 10 months ago
6	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about FDA rejecting MDMA; a nasal spray for allergic reactions, and more - 3 months ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Declines to Approve MDMA for PTSD - 3 months ago Psychedelic Medicine Could Fill Care Gap in Psychiatric Care - 7 months ago Is 2024 the Year for Psychedelic Medicine? - 7 months ago FDA Accepts New Drug Application for MDMA-Assisted Therapy for PTSD - 9 months ago
8	Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York consciousnesseconomicspodcasting	MDMA therapy didn’t get FDA approval. Now what? - 3 months ago How should we sell psychedelics? - 4 months ago Psychedelics are about to become a casualty of Oregon’s opioid crisis - 8 months ago China’s emerging psychedelic scene looks a lot like Silicon Valley - 8 months ago Why psychedelics produce some of the most meaningful experiences in people’s lives - 12 months ago Robin Carhart-Harris studies psychedelics to understand the mind - 12 months ago Psychedelics can have enormous benefits, but the risks shouldn’t be ignored - about 1 year ago
9	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	The Promise of 'Magic Mushrooms' for Mental Health Is Real - 3 months ago
10	The Conversation Science Alert Science news. Official account. Australia science news	Scientists Reveal What Your Brain Looks Like on Psilocybin - 3 months ago

Journalists covering psilocybin